Management and outcome of patients with atrial fibrillation during acute myocardial infarction: The GUSTO-III experience

Heart

Volumn 88, Issue 4, 2002, Pages 357-362

  Wong, C K ^a,f   White, Harvey D ^a   Wilcox, R G ^b   Criger, D A ^c   Califf, R M ^c   Topol, E J ^d   Ohman, E M ^e  

^a GREEN LANE HOSPITAL   (New Zealand)

^b NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^c DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF NORTH CAROLINA   (United States)

^f CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; DILTIAZEM; DISOPYRAMIDE; ENCAINIDE; ESMOLOL; FLECAINIDE; METOPROLOL; PROCAINAMIDE; PROPAFENONE; QUINIDINE; SOTALOL; VERAPAMIL;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CARDIOVERSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; SINUS RHYTHM; TREATMENT OUTCOME;

EID: 0036785064     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.88.4.357     Document Type: Article

References (14)

1. Wong CK, White HD, Wilcox RG, et al for the GUSTO-III investigators. New atrial fibrillation after acute myocardial infarction independently predicts mortality: the GUSTO-III experience. Am Heart J 2000;140:878-85.
2. Coplen SE, Antman EM, Berlin JA, et al. Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized controlled trials. Circulation 1990;82:1106-16.
3. Roy D, Talajic M, Dorian P, et al. Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation investigators. N Engl J Med 2000;342:913-20.
4. Echt DS, Liebson PR, Mitchell LB, et al for the CAST Investigators. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The cardiac arrhythmia suppression trial. N Engl J Med 1991;324:781-8.
5. Cairns JA, Connolly SJ, Roberts R, et al. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian amiodarone myocardial infarction trial investigators. Lancet 1997;349:675-82.
6. Julian DG, Camm AJ, Frangin G, et al for the European Myocardial Infarct Amiodarone Trial Investigators. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. Lancet 1997;349:667-74.
7. The GUSTO III Investigators. A comparison of reteplase with alteplase for acute myocardial infarction. N Engl J Med 1997;337:1118-23.
8. Vaughan Williams EM. The relevance of cellular to clinical electrophysiology in classifying antiarrhythmic actions. J Cardiovasc Pharmacol 1992;20:S1-7.
9. Crenshaw BS, Ward SR, Granger CB, et al for the GUSTO-I trial investigators. Atrial fibrillation in the setting of acute myocardial infarction: the GUSTO-I experience. J Am Coll Cardiol 1997;30:406-13.
10. Eldar M, Canetti M, Rotstein Z, et al for the SPRINT and Thrombolytic Survey Groups. Significance of paroxysmal atrial fibrillation complicating acute myocardial infarction in the thrombolytic era. Circulation 1998;97:965-70.
11. Pedersen OD, Bagger H, Kober L, et al for the TRACE Study Group. The occurrence and prognostic significance of atrial fibrillation/flutter following acute myocardial infarction. Eur Heart J 1999;20:748-54.
12. The Cardiac Arrhythmia Suppression Trial II Investigators. Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. N Engl J Med 1992;327:227-33.
13. Waldo AL, Camm AJ, deRuyter H, et al for the SWORD Investigators. Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. Lancet 1996;348:7-12.
14. Teo KK, Yusuf S, Furberg CD. Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. An overview of results from randomized controlled trials. JAMA 1993;270:1589-95.